ABBV trailing returns
AbbVie Inc.'s 10-year annualized return is +20.1% per year (+524.9% cumulative). How AbbVie Inc. (ABBV) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through July 2, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-07-02. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | +4.0% | |
| 1 week | — | +7.4% | |
| 1 month | — | +21.2% | |
| YTD | — | +16.1% | |
| 1 year | +41.9% | +41.9% | |
| 5 years | +22.4% | +174.7% | |
| 10 years | +20.1% | +524.9% | |
| Since inception (2013) | +20.7% | +1160.9% |
Growth of ABBV#
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-07-02). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from ABBV's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ
- What is AbbVie Inc.'s 10-year return?
- Over the last 10 years, AbbVie Inc. (ABBV) returned about +20.1% a year annualized (+524.9% cumulative total return).
- What is AbbVie Inc.'s return since inception?
- Since 2013, AbbVie Inc. (ABBV) has compounded at about +20.7% a year — +1160.9% in total.